Vitamin Shoppe, Inc.
(VSI - Snapshot Report
consistently provides positive earnings surprises and the
stock remains a Zacks #1 Rank (Strong Buy).
Vitamin Shoppe is a retailer of nutritional products like
vitamins, minerals, supplements, homeopathic remedies and
other similar items. The company owns approximately 500
stores and also sells through catalogs and its website.
Positive Earnings Surprise
VSI has beaten the Zacks Consensus Earnings Estimate in five
of the last six earnings releases and met expectations one
time. The average beat for 2011 has been 16% ahead of
expectations, an amount that gets the attention of aggressive
Earnings per share for the most recent quarter came in at
$0.40, $0.07 ahead of the Zacks Consensus Earnings Estimate
of $0.33. That beat was fully 21% ahead of expectations.
Since that time, three more analysts have contributed their
earnings to the consensus, and the expectation of $0.32 is
one cent below the prior quarters expectation.
Management Speaking 1/12/12
Speaking at the start of earnings season is inherently
risky. Should the conference get cancelled or a plane not
make it on time, the lack of a presentation can be
interpreted negatively. A smooth presentation that has a
good tone and positive answers to investors questions can
lead to further confidence for earnings outperformance. We
note that this is not a brokerage related conference.
Shares of VSI are not cheap by most metrics, trading at a
premium to both trailing and forward PE when compared to the
industry. The real metric that stands out is the price to
sales, with VSI trading at 1.45x trailing twelve months
sales while the industry trades at only 0.4x sales. We
believe that VSI is trading at a significant premium to the
industry due to its currently low market share rate of 2.2%
and the expectation that its market share will rise.
VSI has a limited public operating history, but the positive
earnings surprises and increases in earnings help make the
stock a Zacks #1 Rank (Strong Buy). A look at the earnings
surprise chart show that management has done a good job of
Brian Bolan is the Aggressive Growth Stock Strategist for
Zacks.com. He is also the Editor in charge of the Zacks Home Run Investor